OpportunityTitle: Spinal Muscular Atrophy (SMA) Biomarker Study (U01)
AdditionalInformationOnEligibility: Other Eligible Applicants include the following:  Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply, but will have to work with the U.S.-based NeuroNEXT infrastructure.
Description: The purpose of this funding opportunity announcement (FOA), issued by NINDS, is to invite applications for a study of candidate biomarkers in Spinal Muscular Atrophy (SMA). The study will be done using the NeuroNEXT infrastructure (as established in response to RFA-NS-11-009, RFA-NS-11-010, RFA-NS-11-008) along with ad hoc clinical sites as appropriate. This is a milestone-driven cooperative agreement program involving participation of NIH staff in the development of the project plan and monitoring of research progress.
GrantorContactEmailDescription: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
GrantorContactText: NIH OER Webmaster&lt;br/&gt;FBOWebmaster@OD.NIH.GOV&lt;br/&gt;